Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.48 |
| ▸ | DRD2 | P14416 | 5/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.43 |
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7535737 | 0.88 | HTR1A (0.46) | HTR1ADRD2SLC6A4HTR7HTR2A | |
| SCHEMBL7535732 | 0.88 | HTR1A (0.51) | HTR1ADRD2SLC6A4HTR7HTR2A | |
| SCHEMBL7532686 | 0.86 | DRD2 (0.59) | HTR1ADRD2ABCC1HTR7HTR2A | |
| SCHEMBL7534426 | 0.79 | DRD2 (0.56) | HTR1ADRD2ABCC1HTR7HTR2A | |
| SCHEMBL7532864 | 0.79 | DRD2 (0.55) | HTR1ADRD2SLC6A4HTR7HTR6 | |
| SCHEMBL7538171 | 0.77 | DRD2 (0.55) | HTR1ADRD2ABCC1HTR7HTR2A | |
| SCHEMBL7849769 | 0.73 | HTR1A (0.39) | HTR1ASLC6A4 | |
| SCHEMBL9696701 | 0.71 | DRD2 (0.52) | HTR1ADRD2HTR2AHTR6KCNH2 | |
| SCHEMBL6611400 | 0.71 | DRD2 (0.66) | HTR1ADRD2 | |
| SCHEMBL6191888 | 0.70 | ROCK2 (0.60) | HTR1ADRD2HTR7HTR2AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | H. LUNDBECK A/S (DK) | 2002-09-12 | — | — | US | claimed |
| US-6391882-B1 | PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 2002-05-21 | — | — | US | claimed |
| CN-1336925-A | 4,5,6 and 7-indole and indoline derivatives, their prepn. and use | LUNDBECK & CO AS H (DK) | 2002-02-20 | — | — | CN | claimed |
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | H. LUNDBECK A/S (DK) | 2002-09-12 | — | — | US | disclosed |
| US-6391882-B1 | PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 2002-05-21 | — | — | US | disclosed |
| CN-1336925-A | 4,5,6 and 7-indole and indoline derivatives, their prepn. and use | LUNDBECK & CO AS H (DK) | 2002-02-20 | — | — | CN | disclosed |
| EP-1089997-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H.Lundbeck A/S (DK) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067237-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H. LUNDBECK A/S (DK) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | HTR2C, HTR1A, HTR7 | HTR1A 2/4885DRD2 49/4885SLC6A4 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.